Traditional genetic embryo screening methods have been limited by less accurate, non-quantitative lab analysis. IVF success rates have been low as a result of the higher risk of miscarriage and genetic disorders due to aneuploid embryos. With advanced preimplantation genetic screening and karyomapping technology, Illumina advances reproductive health solutions. http://www.illumina.com/clinical/reproductive-genetic-health.ilmn. Learn about the latest advances in reproductive and genetic health from Illumina. Empowering informed choices to change lives.